Fresenius Medical Care AG & Co. KGaAFMS

$23.59+0.02 (+0.08%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$13B
Large-cap
-55%
2016 — today
10-Year Price
-51%
2016 — today
52-Week Range
$20.19$28.77
Current $23.59· 40%

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.

Valuation in context

P/E ratio
14.3
Historically cheap
Historically cheap relative to the last 10 years
P/B ratio
0.9
Near historic low
Near historic low — last 10 years
EV / EBITDA
6.7
Near historic low
Near historic low — last 10 years
Dividend Yield
3.7%
Historically high
Historically high relative to the last 10 years
PEG ratio
2.7
Below average
Below the 10-year average
FCF Yield
13.6%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when FMS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.